Clinical trial
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
NCT01976936 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
- Lead sponsor
- Columbia University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- November 30, 2015
- Enrollment
- 162 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.